Search Filters

Search Results

Found 1 results

510(k) Data Aggregation

    K Number
    K240158
    Date Cleared
    2024-09-04

    (229 days)

    Product Code
    Regulation Number
    880.5725
    Reference & Predicate Devices
    Why did this record match?
    Reference Devices :

    K110771, K021475, K163400

    AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP AuthorizedThirdpartyExpeditedreview
    Intended Use

    The Modular Medical MODD1 Insulin Delivery System is indicated for the subcutaneous delivery of insulin at set and variable rates, for the management of diabetes mellitus in persons requiring insulin, for individuals 18 years of age and greater.

    Device Description

    The Modular Medical MODD1 Insulin Delivery System (i.e., MODD1 System) consists of the following:

    • A reusable, software-controlled programmable Pump,
    • A single-use, disposable 3.0mL (300 unit) Insulin Cartridge with an integrated battery to supply power to the Pump, infusion tubing, and Tubing Cap for attaching to the Infusion Set.
    • . A single-use, disposable Adhesive Pad for affixing the MODD1 System to the user's body and allowing for temporary removal of the MODD1 System,
    • A single-use, disposable Infusion Set inserted into the patient's subcutaneous tissue, and
    • The MMI App, a smartphone application used to program the basal delivery schedule on the Pump.

    Accessories to the MODD1 System are FDA-cleared and include the following:

    • A single-use disposable syringe (K110771) and needle (K021475) used to fill the Insulin Cartridge reservoir, and
    • A reusable Inserter (K163400), optionally used to insert the Infusion Set into the patient's subcutaneous tissue.

    The MODD1 System has been demonstrated to be compatible with Humalog U-100 insulin.

    The MODD1 System can deliver insulin at basal rates between 0.5 - 4 units per hour (programmable in 0.1-unit increments) and user-selected bolus doses of between 2 and 20 units (in 2-unit increments). Basal insulin delivery may also be suspended for a set period of 30 minutes when required by the user.

    The delivery of insulin is achieved by gear motor rotation of a single fixed-position camshaft (components of the Pump controlled by software) that interfaces with the Insulin Cartridge pistons to control the movement of insulin from the insulin reservoir, into an interim chamber, and into the infusion tubing towards the Infusion Set inserted into the patient's subcutaneous tissue. Software monitors dispense output via feedback provided by multiple sensors, providing an alarm when issues with delivery (e.g., malfunctions, low reservoir volume, occlusions) are detected.

    The Pump serves as the primary user interface of the MODD1 System. A Control Button is used to prime the fluid path, program bolus deliveries, check system status, and to temporarily suspend insulin delivery. The multi-color LED and piezo buzzer of the Pump provide audio-visual feedback to the user during the set-up process, programming of a bolus delivery, and changing of delivery modes (e.g., bolus, basal, suspend). Audio-visual feedback is also used to inform the user of system alarms (automatically generated) and system status (when requested by the user).

    The MMI App is downloaded directly onto an Apple® iPhone 12 Pro Max running iOS version 16. The MMI App allows for the configuration of a basal delivery schedule on the Pump, consisting of up to two basal rates in a 24-hour period. The MMI App and Pump communicate using Bluetooth® Low Energy (BLE) and Near Field Communication (NFC). After the basal delivery schedule has been programmed on the Pump, all insulin delivery functions are controlled using the Pump user interface. Optional features of the MMI App include a dashboard display of current and historical Pump information and delivery history.

    AI/ML Overview

    The provided text is a 510(k) Summary for the Modular Medical MODD1 Insulin Delivery System. It details the device, its indications for use, comparison to a predicate device, and a summary of non-clinical performance data.

    However, the document does not provide information on an AI-driven medical device, nor does it conduct a study involving human readers or expert ground truth. It describes the regulatory submission for an insulin pump.

    Therefore, I cannot extract the requested information regarding acceptance criteria, device performance, sample sizes, expert ground truth establishment, adjudication methods, MRMC studies, standalone AI performance, or training set details from the provided text.

    The text describes compliance with various medical device standards (e.g., ISO 14971, IEC 62366-1, ISO 10993-1, IEC 60601-1, IEC 62304) and includes bench testing for infusion delivery accuracy and occlusion detection, but these are part of standard medical device validation, not specific to AI performance as requested in the prompt.

    Ask a Question

    Ask a specific question about this device

    Page 1 of 1